Mariana Castells | |
---|---|
Maria Concepcion Castells | |
Alma mater | Autonomous University of Barcelona |
Known for | mastocytosis, drug desensitization |
Scientific career | |
Fields | allergy and immunology |
Institutions | Harvard Medical School, Brigham and Women's Hospital |
Mariana Castells is a Spanish-American allergist who focuses on mast cell diseases, including mastocytosis, mast cell activation syndrome and hereditary alpha tryptasimia. Mastocytosis is a rare disease with limited treatment options. [1] Castells works at Brigham and Women's Hospital in Massachusetts in the Department of Allergy, Rheumatology, and Immunology and at the Dana Farber Cancer Institute. [1] [2] [3] She is also a professor of medicine at Harvard Medical School. [4] [5]
Castells attended medical school at Autonomous University of Barcelona, Spain and was a resident at University of Kansas Medical Center. [4] She also has a PhD. [6] [7]
Castells is a leader in the mastocytosis treatment and research field, and directs both the Mastocytosis Center of Excellence and the Drug Hypersensitivity and Desensitization Center at Brigham and Women's Hospital. [8] [7] [9] [10] She is also part of the medical advisory board for The Mastocytosis Society. [11] [12] Castells leads clinical trials related to both mast cell disease and drug desensitization. [13] [14] [15] In her desensitization research, she works to reduce allergic reactions to chemotherapy and other kinds of drugs. [3] [16] [17] [18]
Castells is often quoted as an expert in media articles about seasonal environmental allergies. [1] [19] [20] [21] [22]
Mariana Castells | |
---|---|
Maria Concepcion Castells | |
Alma mater | Autonomous University of Barcelona |
Known for | mastocytosis, drug desensitization |
Scientific career | |
Fields | allergy and immunology |
Institutions | Harvard Medical School, Brigham and Women's Hospital |
Mariana Castells is a Spanish-American allergist who focuses on mast cell diseases, including mastocytosis, mast cell activation syndrome and hereditary alpha tryptasimia. Mastocytosis is a rare disease with limited treatment options. [1] Castells works at Brigham and Women's Hospital in Massachusetts in the Department of Allergy, Rheumatology, and Immunology and at the Dana Farber Cancer Institute. [1] [2] [3] She is also a professor of medicine at Harvard Medical School. [4] [5]
Castells attended medical school at Autonomous University of Barcelona, Spain and was a resident at University of Kansas Medical Center. [4] She also has a PhD. [6] [7]
Castells is a leader in the mastocytosis treatment and research field, and directs both the Mastocytosis Center of Excellence and the Drug Hypersensitivity and Desensitization Center at Brigham and Women's Hospital. [8] [7] [9] [10] She is also part of the medical advisory board for The Mastocytosis Society. [11] [12] Castells leads clinical trials related to both mast cell disease and drug desensitization. [13] [14] [15] In her desensitization research, she works to reduce allergic reactions to chemotherapy and other kinds of drugs. [3] [16] [17] [18]
Castells is often quoted as an expert in media articles about seasonal environmental allergies. [1] [19] [20] [21] [22]